176 related articles for article (PubMed ID: 31053636)
21. Recent Trends in Synchronous Brain Metastasis Incidence and Mortality in the United States: Ten-Year Multicenter Experience.
Che W; Liu J; Fu T; Wang X; Lyu J
Curr Oncol; 2022 Nov; 29(11):8374-8389. PubMed ID: 36354720
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of clinical characteristics on risk and prognosis of synchronous brain metastases in small-cell lung cancer patients: A population-based study.
Zhou G; Zhang Z; Yu P; Geng R; Wang G; Ma W; Gao J; Zheng Z; Li Y
Cancer Med; 2023 Jan; 12(2):1195-1203. PubMed ID: 35831985
[TBL] [Abstract][Full Text] [Related]
23. Temporal and gender-related trends in brain metastases from lung and breast cancer.
Yawn BP; Wollan PC; Schroeder C; Gazzuola L; Mehta M
Minn Med; 2003 Dec; 86(12):32-7. PubMed ID: 14719614
[TBL] [Abstract][Full Text] [Related]
24. Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data.
Davis FG; Dolecek TA; McCarthy BJ; Villano JL
Neuro Oncol; 2012 Sep; 14(9):1171-7. PubMed ID: 22898372
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.
Gold HT; Do HT
Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533
[TBL] [Abstract][Full Text] [Related]
26. A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology, and End Results Program.
Mettlin CJ; Menck HR; Winchester DP; Murphy GP
Cancer; 1997 May; 79(10):2052-61. PubMed ID: 9149035
[TBL] [Abstract][Full Text] [Related]
27. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
28. The effect of distant metastases sites on survival in de novo stage-IV breast cancer: A SEER database analysis.
Wu SG; Li H; Tang LY; Sun JY; Zhang WW; Li FY; Chen YX; He ZY
Tumour Biol; 2017 Jun; 39(6):1010428317705082. PubMed ID: 28653887
[TBL] [Abstract][Full Text] [Related]
29. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
[TBL] [Abstract][Full Text] [Related]
30. Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England.
Shack L; Jordan C; Thomson CS; Mak V; Møller H;
BMC Cancer; 2008 Sep; 8():271. PubMed ID: 18822122
[TBL] [Abstract][Full Text] [Related]
31. Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study.
Cagney DN; Martin AM; Catalano PJ; Redig AJ; Lin NU; Lee EQ; Wen PY; Dunn IF; Bi WL; Weiss SE; Haas-Kogan DA; Alexander BM; Aizer AA
Neuro Oncol; 2017 Oct; 19(11):1511-1521. PubMed ID: 28444227
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the Completeness of Managed Care Data to Identify Cancer Diagnoses and Treatments for Patients in the SEER-Medicare Data.
Warren JL; Parsons HM; Mariotto AB; Boyd E; Enewold L
Med Care; 2023 Dec; 61(12):846-857. PubMed ID: 37796197
[TBL] [Abstract][Full Text] [Related]
33. Subsequent thoracic cancers among patients diagnosed with lung cancer: a SEER database analysis.
Abdel-Rahman O; Cheung WY
Curr Med Res Opin; 2017 Nov; 33(11):2009-2017. PubMed ID: 28532174
[TBL] [Abstract][Full Text] [Related]
34. Use of surveillance, epidemiology, and end results-medicare data to conduct case-control studies of cancer among the US elderly.
Engels EA; Pfeiffer RM; Ricker W; Wheeler W; Parsons R; Warren JL
Am J Epidemiol; 2011 Oct; 174(7):860-70. PubMed ID: 21821540
[TBL] [Abstract][Full Text] [Related]
35. Analysis of Sociodemographic, Clinical, and Genomic Factors Associated With Breast Cancer Mortality in the Linked Surveillance, Epidemiology, and End Results and Medicare Database.
Robinson TJ; Wilson LE; Marcom PK; Troester M; Lynch CF; Hernandez BY; Parrilla E; Brauer HA; Dinan MA
JAMA Netw Open; 2021 Oct; 4(10):e2131020. PubMed ID: 34714340
[TBL] [Abstract][Full Text] [Related]
36. Risk-adjusted cancer-incidence rates (United States).
Merrill RM; Feuer EJ
Cancer Causes Control; 1996 Sep; 7(5):544-52. PubMed ID: 8877053
[TBL] [Abstract][Full Text] [Related]
37. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.
Galper S; Gelman R; Recht A; Silver B; Kohli A; Wong JS; Van Buren T; Baldini EH; Harris JR
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):406-14. PubMed ID: 11872286
[TBL] [Abstract][Full Text] [Related]
38. Population-based validation of the National Cancer Comprehensive Network recommendations for baseline imaging workup of cutaneous melanoma.
Abdel-Rahman O
Melanoma Res; 2019 Feb; 29(1):53-58. PubMed ID: 30362976
[TBL] [Abstract][Full Text] [Related]
39. Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases.
Ascha MS; Wang JF; Kumthekar P; Sloan AE; Kruchko C; Barnholtz-Sloan JS
Sci Rep; 2019 Nov; 9(1):17792. PubMed ID: 31780762
[TBL] [Abstract][Full Text] [Related]
40. Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United States.
Halasz LM; Weeks JC; Neville BA; Taback N; Punglia RS
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):e109-16. PubMed ID: 23058058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
